Devices › Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
Device brand name · Catheter percutaneous cardiac ablation for treatment of atrial fibrillation
TactiCath Contact Force Ablation Catheter, Sensor Enabled BiD Curve D-F: medical device reports filed with FDA
1,088 reports name it, 2017–2026. Manufacturer given most often on reports: St Jude Medical. Product code OAE.
- 1,088
- device reports naming the brand
- 0% of all MAUDE reports · about 122 a year
- 38
- reports, 12 months to August 2026
- 55 in the 12 months before
- 43.4%
- classified as malfunction
- 49% across the product code
- 2.4%
- classified as death, as reported
- 26 reports · not verified by FDA
1,088 medical device reports received by FDA name the brand "TactiCath Contact Force Ablation Catheter, Sensor Enabled BiD Curve D-F" (catheter percutaneous cardiac ablation for treatment of atrial fibrillation); the manufacturer given most often on reports is St Jude Medical; received from August 2017 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
38 reports arrived in the 12 months to August 2026, down 31% from 55 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (54.2%), malfunction (43.4%) and death (2.4%); across all catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation reports (product code OAE) death is recorded in 3% and malfunction in 49%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are optical problem (18%), communication or transmission problem (12.8%) and patient device interaction problem (8.3%). The patient problems coded most often are cardiac perforation, stroke/cva and thrombosis/thrombus. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 11,466 reports carrying product code OAE. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Optical problem | 196 | 18% | 4.3% |
| Communication or transmission problemthe device could not communicate or transmit | 139 | 12.8% | 2.9% |
| Patient device interaction problem | 90 | 8.3% | 8.3% |
| Fracturea broken bone | 68 | 6.3% | 2.1% |
| High impedance | 27 | 2.5% | 0.5% |
| Electrical shorting | 15 | 1.4% | 1.1% |
| Display or visual feedback problem | 13 | 1.2% | 0.7% |
| Impedance problem | 13 | 1.2% | 0.4% |
| Signal artifact/noise | 13 | 1.2% | 1% |
| Fluid/blood leak | 8 | 0.7% | 3.3% |
| Material deformation | 7 | 0.6% | 1.6% |
| Obstruction of flow | 5 | 0.5% | 1% |
| Material separation | 4 | 0.4% | 0.3% |
| Output problem | 4 | 0.4% | 0.1% |
| Overheating of device | 4 | 0.4% | 0.5% |
| Activation, positioning or separation problem | 3 | 0.3% | 0.1% |
| Device contamination with body fluid | 3 | 0.3% | 5.8% |
| Failure to analyze signal | 3 | 0.3% | 0.1% |
| Connection problema connection problem | 2 | 0.2% | 0.2% |
| Contamination | 2 | 0.2% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Cardiac perforation | 384 | 35.3% |
| Stroke/cva | 46 | 4.2% |
| Thrombosis/thrombus | 34 | 3.1% |
| Thrombus | 30 | 2.8% |
| Heart block | 21 | 1.9% |
| Perforation of esophagus | 17 | 1.6% |
| Arrhythmia | 12 | 1.1% |
| Deaththe patient died; cause not stated by this term | 9 | 0.8% |
| Complete heart block | 6 | 0.6% |
| Fistula | 6 | 0.6% |
| Pericarditisinflammation of the sac around the heart | 6 | 0.6% |
| Air embolism | 5 | 0.5% |
| Pericardial effusionfluid around the heart | 5 | 0.5% |
| Embolus | 4 | 0.4% |
| Stenosis | 4 | 0.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | TactiCath Contact Force Ablation Catheter, Sensor Enabled BiD Curve D-F | Product code OAE | All MAUDE reports |
|---|---|---|---|
| Reports | 1,088 | 11,466 | 26,136,888 |
| Share of that pool | — | 9.5% | 0% |
| Classified as death, per 1,000 reports | 24 | 30 | 9 |
| Classified as injury | 54.2% | 47.9% | 36.2% |
| Classified as malfunction | 43.4% | 49% | 62.3% |
| Filed by the manufacturer | 100% | 97.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code OAE
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Arctic Front Advance Cardiac Cryoablation Catheter | 2,364 | 46 | 2.6% |
| Arctic Front Advance Pro Cardiac Cryoablation Catheter | 1,727 | 152 | 2.5% |
| QDOT Micro | 1,169 | 390 | 3% |
| Tacticath Quartz Contact Force Ablation Catheter 75mm | 633 | 0 | 3.3% |
| Qdot Micro Catheter | 538 | 37 | 3.5% |
| TactiFlex Ablation Catheter, Sensor Enabled | 514 | 164 | 3.7% |
| IntellaNav StablePoint Open-Irrigated | 376 | 33 | 1.1% |
| TactiCath Contact Force Ablation Catheter, Sensor Enabled | 305 | 34 | 6.9% |
| Polarxfit | 235 | 17 | 1.7% |
| TactiCath Contact Force Ablation Catheter, Sensor Enabled BiD Curve F-J | 219 | 6 | 2.7% |
| Tacticath Quartz Contact Force Ablation Catheter 65mm | 208 | 0 | 3.8% |
| TactiCath Contact Force Ablation Catheter, Sensor Enabled UniD Curve D | 188 | 11 | 1.6% |
| Heartlight | 206 | 0 | 1% |
| Tactisys Quartz Ablation System | 155 | 16 | 0% |
| TactiCath Contact Force Ablation Catheter, Sensor Enabled UniD Curve F | 151 | 4 | 4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about TactiCath Contact Force Ablation Catheter, Sensor Enabled BiD Curve D-F reports
How many FDA reports name TactiCath Contact Force Ablation Catheter, Sensor Enabled BiD Curve D-F?
1,088 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 38 in the latest 12 months.
What kinds of events are reported?
injury (54.2%), malfunction (43.4%) and death (2.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
optical problem (18%), communication or transmission problem (12.8%), patient device interaction problem (8.3%), fracture (6.3%) and high impedance (2.5%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that TactiCath Contact Force Ablation Catheter, Sensor Enabled BiD Curve D-F was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.